XML 41 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Tables)
9 Months Ended
Oct. 28, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Expense

Share-based compensation expense was recognized as follows:

 

     Three Months Ended      Nine Months Ended  
(In thousands)    October 28,
2017
     October 29,
2016
     October 28,
2017
     October 29,
2016
 

Stock Options

   $ 105      $ 85      $ 316      $ 253  

Restricted Stock Awards and Restricted Stock Units

     436        96        800        468  

Employee Stock Purchase Plan

     3        4        9        10  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 544      $ 185      $ 1,125      $ 731  
  

 

 

    

 

 

    

 

 

    

 

 

 
Fair Value of Stock Options Granted

The fair value of stock options granted during the nine months ended October 28, 2017 and October 29, 2016 was estimated using the following weighted average assumptions:

 

     Nine Months Ended  
     October 28,
2017
    October 29,
2016
 

Risk Free Interest Rate

     1.7     1.4

Expected Volatility

     37.9     28.3

Expected Life (in years)

     8.0       5.0  

Expected Dividend Yield

     2.2     1.9
Aggregated Information Regarding Stock Options Granted

Aggregated information regarding stock options granted under the plans for the nine months ended October 28, 2017, is summarized below:

 

     Number of
Options
     Weighted Average
Exercise Price
 

Outstanding at January 31, 2017

     685,456      $ 11.96  

Granted

     132,189        13.45  

Exercised

     (66,550      10.60  

Forfeited

     (18,750      14.49  

Canceled

     (24,600      11.76  
  

 

 

    

 

 

 

Outstanding at October 28, 2017

     707,745      $ 12.31  
  

 

 

    

 

 

 
Summary of Options Outstanding

Set forth below is a summary of options outstanding at October 28, 2017:

 

Outstanding

     Exercisable  

Range of

Exercise prices

   Number
of
Shares
     Weighted-
Average
Exercise
Price
     Weighted-
Average
Remaining
Contractual Life
     Number
of
Shares
     Weighted-
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Life
 

$5.00-10.00

     171,631      $ 7.84        3.2        171,631      $ 7.84        3.2  

$10.01-15.00

     486,114      $ 13.61        7.7        261,325      $ 13.48        6.9  

$15.01-20.00

     50,000      $ 15.01        8.4        12,500      $ 15.01        8.3  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     707,745      $ 12.31        6.6        445,456      $ 11.35        5.5  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
Aggregated Information Regarding RSUs and RSAs Granted

Aggregated information regarding RSUs and RSAs granted under the Plan for the nine months ended October 28, 2017 is summarized below:

 

     RSAs & RSUs      Weighted Average
Grant Date Fair Value
 

Unvested at January 31, 2017

     213,868      $ 14.08  

Granted

     21,295        14.22  

Vested

     (49,935      14.36  

Forfeited

     (9,087      14.05  
  

 

 

    

 

 

 

Unvested at October 28, 2017

     176,141      $ 14.02